Upstate Active Clinical Trials

Study Title:

A Phase II, single-blind, randomized, controlled study to evaluate the
immunogenicity and safety of a measles, mumps, rubella, varicella vaccine compared with
ProQuad, administered in healthy children 4 to 6 years of age

What is the purpose of the study? (in Layman's terms, please describe the study)

A study on the immune response and safety of various potencies of an investigational measles, mumps, rubella, varicella (MMRV) vaccine compared with a marketed MMRV vaccine, given to healthy children 4 to 6 years of age.

Upstate Institutional Review Board (IRB) Number:

1997964

Study/Protocol ID:

217715

Study Phase:

Phase II

Patient Age Group:

Children

Principal Investigator:

Joseph B Domachowske

What is involved if I participate?

• How long is the study?
  181 Days
• Is transportation provided or reimbursed?
  Yes
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  1 blood test drawn at 3rd visit

Where will the study take place?

Upstate Nappi Wellness Institute
725 E. Adams St.
Syracuse, NY 13210

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT05630846

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Nishat Anwar, MD,MPH
Phone: 315-464-7505
Email: [email protected]

Return to Previous Page || Search Again